Ferguson Enterprises <FERG.N>: Oppenheimer Raises Target Price to $288 From $280
FERG•Related News
Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
MREO•
Vertex Pharmaceuticals Incorporated <VRTX.O>: BofA Global Research adds stock to its US 1 list
VRTX•
BridgeBio Pharma, Inc. <BBIO.O>: Truist Securities raises target price to $107 from $102
BBIO•
Cyabra names Keith E. Noble VP of U.S. government sales
CYAB•
Signet Jewelers Announces New Leadership For Zales, Banter And Blue Nile
SIG•